Hartmut Beck

9PUBLICATIONS
111CO-AUTHORS
Proteins and peptidesCheminformatics and quantitative structure-activity relationshipsSequence analysisBiologically active moleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 19, 2026
Identification of the Piperidyl Urea Derivative BAY-439 as a Potent and Selective Inhibitor of Human Phospholipase A2 Group V (hPLA2-G5) for the Treatment of Inflammatory Pain.

|Jan 21, 2026
CACHE Challenge #3: Targeting the Nsp3 Macrodomain of SARS-CoV-2.

Oleksandra Herasymenko, Madhushika Silva, Galen J Correy

|Jun 20, 2025
CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13.

Oleksandra Herasymenko, Madhushika Silva, Abd Al-Aziz A Abu-Saleh

|Jun 11, 2025
Discovery of BAY 3389934 Hydrochloride: A Potent and Selective Small-Molecule Dual Factor IIa/Xa Inhibitor with Short Half-Life for the Acute Treatment of Sepsis-Induced Coagulopathy.

Hartmut Beck, Stefanie Mesch, Stefanie Zimmermann

|Nov 05, 2024
CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson's Disease Associated Protein.

Fengling Li, Suzanne Ackloo, Cheryl H Arrowsmith

|Jun 26, 2023
Target 2035 - an update on private sector contributions.

Suzanne Ackloo, Albert A Antolin, Jose Manuel Bartolome

Pageof 2

Frequent Collaborators

4 joint publications

Matthieu Schapira

4 joint publications

Aled M Edwards

3 joint publications

Rachel J Harding

3 joint publications

Judith Günther